Sight Sciences (SGHT)
(Delayed Data from NSDQ)
$3.60 USD
-0.09 (-2.44%)
Updated Sep 19, 2025 04:00 PM ET
After-Market: $3.60 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value B Growth C Momentum D VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
SGHT 3.60 -0.09(-2.44%)
Will SGHT be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for SGHT based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for SGHT
SGHT Shares Rise on Meta-Analysis Showing OMNI's Long-Term Benefits
Glaukos Builds Dual Growth Engines Amid Market Headwinds
SGHT: What are Zacks experts saying now?
Zacks Private Portfolio Services
Compared to Estimates, Sight Sciences (SGHT) Q2 Earnings: A Look at Key Metrics
Sight Sciences, Inc. (SGHT) Reports Q2 Loss, Tops Revenue Estimates
Veracyte (VCYT) Tops Q2 Earnings and Revenue Estimates
Other News for SGHT
SGHT forms NR7 on September 19
SGHT forms Stochastic Buy Signal on September 18
Technical picture remains unchanged for SGHT after it falls 2.01% on September 17
Needham medtech & diagnostics analysts hold analyst/industry conference call
SGHT's price falls by 0.85% on September 16, though its technical setup remains stable.